Published with kind permission of MEDNOUS The European Medicines Agency has announced the start of a safety review of the Novartis treatment for multiple sclerosis, Gilenya (fingolimod), less than a year after the dr... more »
From the very beginning of modern biology, cell separation from complex biological samples has always been a crucial issue. The progress made in immunology and stem cell technologies is entirely inconceivable without the... more »
Looking for special service?
Don't spend time on search!
Get applications from providers For Free